MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

How long is the wait to see a Parkinson’s disease specialist in the United States?

S.G. Reich, K. Holmes, J. Martello, K. Maki (Baltimore, MD, USA)

Meeting: 2016 International Congress

Abstract Number: 538

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Quality of life/caregiver burden in movement disorders

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate the wait time to see a PD specialist in the US.

Background: PD patients who see a specialist have better outcomes and are more likely to receive treatment in accordance with AAN recommendations. The UK National Institute for Health and Care Excellence guidelines state that patients with mild PD should see a specialist within 6 weeks of referral and within 2 weeks for more advanced PD. In the US, there is no equivalent guideline. Prompted by hearing concerns by PD patients about the difficulty obtaining an appointment with a specialist, we investigated the wait time.

Methods: 147 US PD centers were identified from the Parkinson’s disease Foundation’s website and from the National Parkinson’s Foundation’s Centers of Excellence. Contact information and number of PD specialists at each center were identified from the internet. Each site was contacted by phone and asked about the next available appointment.

Results: One hundred and fourteen centers (78%) provided the next available appointment date; 33 (22%) refused to participate or were not able to provide the information. The average wait time was 2.2 months (SD=1.8) with a range of 1 day to 8 months. Fifty percent of centers (n=57) had wait times longer than 2 months and approximately one quarter (n=33) had wait times > 3 months. The wait time did not correlate with the number of PD specialists at a center (r=-.09, p=.37). The Figure shows the distribution of wait times

Conclusions: This study demonstrates great variability in the time to see a PD specialist in the US ranging from as little as 1 day to as long as 8 months. For many centers, the wait was > 3 months. Neither the variability nor duration in wait time correlated with the number of PD specialists at a center suggesting that further research is necessary to determine what contributes to these factors. The long wait time at most PD centers makes it essential to develop novel methods to ensure that PD patients have prompt access to specialty care.

This abstract has not been previously presented; however a version was submitted for consideration to the AAN 2016 meeting.

To cite this abstract in AMA style:

S.G. Reich, K. Holmes, J. Martello, K. Maki. How long is the wait to see a Parkinson’s disease specialist in the United States? [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/how-long-is-the-wait-to-see-a-parkinsons-disease-specialist-in-the-united-states/. Accessed May 22, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/how-long-is-the-wait-to-see-a-parkinsons-disease-specialist-in-the-united-states/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley